Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 8026702, 14 pages
http://dx.doi.org/10.1155/2016/8026702
Research Article

Targeting TRPM2 Channels Impairs Radiation-Induced Cell Cycle Arrest and Fosters Cell Death of T Cell Leukemia Cells in a Bcl-2-Dependent Manner

1Department of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany
2Department of Physiology, University of Tübingen, 72076 Tübingen, Germany
3Department of Oral & Maxillofacial Surgery, The University of Texas Health Science Center, San Antonio, TX 78229, USA
4Institute for Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany

Received 22 June 2015; Accepted 15 October 2015

Academic Editor: Lokesh Deb

Copyright © 2016 Dominik Klumpp et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Messenger RNA data of lymphohematopoietic cancer lines suggest a correlation between expression of the cation channel TRPM2 and the antiapoptotic protein Bcl-2. The latter is overexpressed in various tumor entities and mediates therapy resistance. Here, we analyzed the crosstalk between Bcl-2 and TRPM2 channels in T cell leukemia cells during oxidative stress as conferred by ionizing radiation (IR). To this end, the effects of TRPM2 inhibition or knock-down on plasma membrane currents, Ca2+ signaling, mitochondrial superoxide anion formation, and cell cycle progression were compared between irradiated (0–10 Gy) Bcl-2-overexpressing and empty vector-transfected Jurkat cells. As a result, IR stimulated a TRPM2-mediated Ca2+-entry, which was higher in Bcl-2-overexpressing than in control cells and which contributed to IR-induced G2/M cell cycle arrest. TRPM2 inhibition induced a release from G2/M arrest resulting in cell death. Collectively, this data suggests a pivotal function of TRPM2 in the DNA damage response of T cell leukemia cells. Apoptosis-resistant Bcl-2-overexpressing cells even can afford higher TRPM2 activity without risking a hazardous Ca2+-overload-induced mitochondrial superoxide anion formation.

1. Introduction

Transient Receptor Potential (TRP) Cation Channels. The TRP superfamily comprises a diverse range of Ca2+-permeable cation channels [1]. TRP channels contribute to changes in cytosolic free Ca2+ () by directly acting as Ca2+ entry channels in the plasma membrane or by changing membrane potentials, modulating the activity and/or driving forces for the Ca2+ entry channels [2]. The melastatin subfamily (TRPM) has been subdivided into three subgroups on the basis of sequence homology (TRPM1/TRPM3, TRPM4/TRPM5, and TRPM6/7) with TRPM8 and TRPM2 being distinct proteins [3]. The Ca2+-permeable TRPM2 channels, formerly known as TRPC2 and LTRPC2, were first identified in 1998 [4]. Reactive oxygen species (ROS) have been demonstrated to induce TRPM2 currents and increase in various cell types transfected with TRPM2 [5], as well as in pancreatic β-cells [6], neutrophil granulocytes [7], and U937 monocytes [8].

TRPM2 and Cell Death. By increasing , TRPM2 may increase the susceptibility to cell death suggesting that TRPM2 channels function as “death channels.” As a matter of fact, heterologous expression of TRPM2 in human embryonic kidney cells [9] or A172 human glioblastoma cells [10] facilitates oxidative stress-induced cell death. Moreover, expression of TRPM2 has been demonstrated in several tumor entities such as insulinoma [6], hepatocellular carcinoma [6], prostate cancer [11], lymphoma [12], leukemia [13], and lung cancer cell lines [14] in which TRPM2 reportedly may foster cell death [15].

Ca2+-Signaling by TRPM2, Bcl-2, and Mitochondria. ROS-induced TRPM2 channel activation most probably occurs indirectly via formation of adenosine diphosphate ribose (ADPR) which activates the channel by binding to a special domain located at the C-terminus of the channel [16]. ADP-ribose polymers are formed during DNA damage response by poly(ADP-ribose) polymerases (PARPs). Upon DNA repair ADPR is released from the ADPR polymers by glycohydrolases [17, 18]. Another main source of ADPR is the mitochondria [19].

Mitochondrial Ca2+ absorbance exerts Ca2+ buffering function (for review see [20]). The mitochondrial respiratory chain and the mitochondrial permeability transition pore (PTP) are regulated by Ca2+. Moderate mitochondrial Ca2+ increase may disinhibit the respiratory chain leading to hyperpolarisation [21] which in turn is accompanied by increasing superoxide anion formation [22]. Mitochondrial Ca2+ overload, in contrast, opens the PTP leading to dissipation, cytochrome C release, and apoptotic cell death [20].

The antiapoptotic protein Bcl-2 is a key player in cellular Ca2+ homeostasis. In some cell models, overexpression of Bcl-2 reportedly may increase the Ca2+ leakage through IP3 receptor subtypes in the ER membrane and decrease the ER Ca2+ filling. More recent studies, in contrast, suggest an inhibition of IP3-receptor-mediated Ca2+ release by Bcl-2. Like Bcl-2-caused Ca2+ store depletion, Bcl-2-mediated IP3-receptor inhibition is thought to prevent proapoptotic bulk Ca2+ release from the ER (for review see [2326]).

Direct and Indirect Oxidative Stress Conferred by Ionizing Radiation. Most energy of ionizing radiation (IR) is absorbed by cell water leading to formation of hydroxyl radicals (for review see [27]). Oxidative stress- and DNA repair-associated release of ADP-ribose is supposed to increase the plasma membrane Ca2+ permeability by activating TRPM2 channels. Subsequent changes in and mitochondrial function are under the control of Bcl-2. Together, this hints to a crosstalk between Ca2+ and ROS signaling involving TRPM2 Ca2+-permeable channels in the plasma membrane, the Ca2+-regulated across the inner mitochondrial membrane, and the antiapoptotic protein Bcl-2 in the ER and outer mitochondrial membrane of irradiated cells.

Aim of the Study. The present study aimed to define this crosstalk in human T cell leukemia cells subjected to ionizing radiation. To this end, Jurkat cells stably transfected with Bcl-2 or the empty control vector were irradiated with 0, 5, or 10 Gy by 6 MV photons. Ion channel activity, Ca2+ signaling, mitochondrial superoxide anion formation, cell cycle control, and cell death were assessed by patch-clamp whole-cell recording, fura-2 Ca2+ imaging, immunoblotting, and flow cytometry in irradiated and nonirradiated cells, respectively. In addition, mRNA data of hematopoietic and lymphoid tissue cancer cell lines of the Novartis and Broad Institute Cancer Cell Line Encyclopedia were queried for TRPM2 and Bcl-2 mRNA abundance.

2. Material and Methods

2.1. Cell Culture

Jurkat E6.1 T cell leukemia cells were from ATCC (Bethesda, Maryland, USA). Jurkat cells stably expressing Bcl-2 (Jurkat-Bcl-2) or a control vector (Jurkat-vector) were prepared as described before [28, 29]. Inducible Bcl-2 transfectants were generated as described [30]. To suppress Bcl-2 expression in Tet-off Jurkat cells, Bcl-2 transfectants were treated with 1 μg/mL doxycycline (Clontech, Heidelberg, Germany) for 48 h. As control cells, the maternal Jurkat Tet-off cells were used. Cells were grown in RPMI 1640 medium supplemented with 10% fetal calf serum (Gibco Life Technologies, Eggenstein, Germany) and maintained in a humidified incubator at 37°C and 5% CO2.

2.2. Transfection with siRNA

Transfection with siRNA was performed as described [31]. In brief, cells were cultured at a low density to ensure log phase growth. For transfection, 2 × 106 cells were resuspended in 200 μL RPMI 1640 without phenol red. Shortly before transfection, TRPM2 or nontargeting siRNA was added at a concentration of 1 μM. TRPM2 ON-TARGET SMARTpool and the siCONTROL NON-TARGETING pool siRNA were purchased from Dharmacon (Chicago, IL, USA). Cells were electroporated in a 4 mm cuvette in an EPI2500 electroporator (Fischer, Heidelberg, Germany) at 370 V for 10 ms. Immediately after transfection, cells were resuspended in 6 mL prewarmed medium and continued to be cultured as described above. Transfection efficiency as well as viability was determined by transfecting the cells with 400 nM green fluorescence siRNA (siGLO from Dharmacon, Chicago, IL, USA) followed by propidium iodide exclusion dye and flow cytometric analysis.

2.3. Patch-Clamp Recording

Maternal, Bcl-2-overexpressing, and control vector-transfected Jurkat cells were irradiated (IR) with 0, 5, or 10 Gy 6 MV photons by the use of linear accelerator (LINAC SL25 Philips) at a dose rate of 4 Gy/min at room temperature. Whole-cell currents were evoked by 9–11 voltage pulses (700 ms each) to voltages between −100 (−80) mV and +100 (+80) mV delivered in 20 mV increments. Mean steady state current values were analyzed 2–49 h after IR. The liquid junction potentials between the pipette and the bath solutions were estimated according to [32], and data were corrected for the estimated liquid junction potentials. Applied voltages refer to the cytoplasmic face of the membrane with respect to the extracellular space. Inward currents, defined as flow of positive charge from the extracellular to the cytoplasmic membrane face, are negative currents and depicted as downward deflections of the original current traces.

Cells were superfused at 37°C temperature with NaCl ringer solution (in mM: 125 NaCl, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), 5 KCl, 5 D-glucose, 1 MgCl2, and 1 CaCl2, titrated with NaOH to pH 7.4). Upon GΩ-seal formation and entry into the whole-cell recording mode, cells were recorded with NaCl bath solution (in mM: 140 NaCl, 10 HEPES titrated with NaOH to pH 7.4), KCl bath solution (in mM: 140 KCl, 10 HEPES titrated with KOH to pH 7.4), CaCl2 bath solution (in mM: 100 CaCl2, 10 HEPES, titrated with Ca(OH)2 to pH 7.4), or N-methyl-D-glucamine-Cl (NMDG-Cl) bath solution (in mM: 180 mM N-methyl-D-glucamine titrated with HCl to pH 7.4). The K-D-gluconate/KCl pipette solution contained (in mM) 60 K-D-gluconate, 80 KCl, 5 HEPES, 1 MgCl2, 1 K2-EGTA, and 1 K2-ATP, titrated with KOH to pH 7.4. To activate TRPM2 channels, ADP-ribose (1 μM, Sigma, Taufkirchen, Germany) was added to the pipette solution. To inhibit TRPM2 and IK channels N-(p-amylcinnamoyl)anthranilic acid (ACA, 0 or 20 μM) and TRAM-34 (0 or 10 μM, both from Sigma, both prepared from a 10 mM stock solution in DMSO) were added to the bath solution, respectively.

2.4. Querying the Cancer Genome Atlas (TGCA) Data Sets

Via the cBIOportal Web resource [33, 34], 178 hematopoietic and lymphoid tissue cancer cell lines of the Novartis and Broad Institute Cancer Cell Line Encyclopedia [35] were queried for TRPM2 and Bcl-2 mRNA abundance.

2.5. Western Blotting

Irradiated Jurkat cells (0, 5, or 10 Gy, 2–4 h after IR) were lysed in a buffer (containing in mM 50 HEPES, pH 7.5, 150 NaCl, 1 EDTA, 10 sodium pyrophosphate, 10 NaF, 2 Na3VO4, 1 phenylmethylsulfonyl fluoride (PMSF) additionally containing 1% triton X-100, 5 μg/mL aprotinin, 5 μg/mL leupeptin, and 3 μg/mL pepstatin) and separated by SDS-PAGE under reducing condition. In some experiments, cells were preincubated (0.25 h), irradiated (5 Gy), and postincubated (4 h) in the presence of the TRPM2 channel inhibitor ACA (20 μM). Segregated proteins were electrotransferred onto PVDF membranes (Roth, Karlsruhe, Germany). Blots were blocked in TBS buffer containing 0.05% Tween 20 and 5% nonfat dry milk for 1 h at room temperature. The membrane was incubated overnight at 4°C with the following primary antibodies: rabbit anti-phospho-CaMKII (Thr286) antibody (Cell Signaling #3361, New England Biolabs, Frankfurt, Germany, 1 : 1000), rabbit anti-CaMKII (pan) antibody (Cell Signaling #3362, 1 : 1000), rabbit anti-phospho-cdc25b (Ser187) antibody (Epitomics #T1162, Biomol Hamburg, Germany, 1 : 1000), rabbit anti-cdc25b antibody (Cell Signaling #9525, 1 : 1000), rabbit-anti TRPM2 (Bethyl Laboratories Inc., #A300-414A-2, Montgomery, TX, USA, 1 : 300), or mouse anti-Bcl-2 antibody (Santa Cruz Biotechnology, sc-509, Heidelberg, Germany, 1 : 1000). Equal gel loading was verified by an antibody against β-actin (mouse anti-β-actin antibody, clone AC-74, Sigma #A2228 1 : 20,000). Antibody binding was detected with a horseradish peroxidase-linked goat anti-rabbit or horse anti-mouse IgG antibody (Cell Signaling #7074 and #7076, resp.; 1 : 1000–1 : 2000 dilution in TBS-Tween/5% milk) incubated for 1 h at room temperature and enhanced chemoluminescence (ECL Western blotting analysis system, GE Healthcare/Amersham-Biosciences, Freiburg, Germany) was detected by film autography.

2.6. Fura-2 Ca2+ Imaging

Fluorescence measurements were performed using an inverted phase-contrast microscope (Axiovert 100; Zeiss, Oberkochen, Germany). Fluorescence was evoked by a filter wheel (Visitron Systems, Puchheim, Germany) mediated alternative excitation at 340/26 or 387/11 nm (AHF, Analysentechnik, Tübingen, Germany). Excitation and emission light was deflected by a dichroic mirror (409/LP nm beamsplitter, AHF) into the objective (Fluar x40/1.30 oil; Zeiss) and transmitted to the camera (Visitron Systems), respectively. Emitted fluorescence intensity was recorded at 587/35 nm (AHF). Excitation was controlled and data acquired by Metafluor computer software (Universal Imaging, Downingtown, PA, USA). The 340/380 nm fluorescence ratio was used as a measure of cytosolic free Ca2+ concentration (). The cells were irradiated (0 or 5 Gy) and loaded with fura-2/AM (2 μM for 30 min at 37°C; Molecular Probes, Goettingen, Germany) in supplemented RPMI medium. was determined 1.5–5 h after IR at 37°C during superfusion with NaCl ringer (see above), upon Ca2+ depletion with Ca2+-free NaCl ringer solution (in mM: 125 NaCl, 32 HEPES, 5 KCl, 5 D-glucose, 1 MgCl2, and 0.5 EGTA, titrated with NaOH to pH 7.4), and during Ca2+ readdition in NaCl ringer solution additionally containing ACA (0 or 20 μM).

2.7. Flow Cytometry

To test for mitochondrial production of superoxide anion, Jurkat cells were irradiated (0 or 10 Gy), further cultured for 6 h, harvested, washed, and incubated for 10 min at 37°C in NaCl ringer solution (see above) containing 5 μM of the superoxide anion-sensitive dye MitoSOX (Invitrogen) and 0 or 20 μM ACA, and superoxide anion-sensitive fluorescence was recorded by flow cytometry in fluorescence channel Fl-2 (logarithmic scale, 488 nm excitation and 564–606 nm emission wavelengths). To confirm equal fluorescence dye loading, samples were oxidized (10 mM tert-butylhydroperoxide) for 12 min and recorded (data not shown).

To monitor mitochondrial function, Jurkat cells were irradiated (0 or 10 Gy) and further cultured for 6 h. Thereafter, cells were harvested, washed, and incubated for 30 min at 37°C in NaCl ringer solution (see above) containing 25 nM of the inner mitochondrial membrane potential () specific dye tetramethylrhodamine ethyl ester perchlorate (TMRE, Invitrogen) and was analyzed by flow cytometry in fluorescence channel FL-2 (logarithmic scale).

For cell cycle analysis, Jurkat cells were preincubated (0.25 h), irradiated (0, 5 or 10 Gy), and incubated for further 24 h in supplemented RPMI 1640 medium additionally containing either ACA or clotrimazole (Sigma, 0 or 20 μM, each). Cells were permeabilized and stained (0.5 h at room temperature) with unsteril (i.e., not RNase-free) propidium iodide (PI) solution (containing 0.1% Na-citrate, 0.1% triton X-100, 10 μg/mL PI in phosphate-buffered saline, PBS), and the DNA amount was analyzed by flow cytometry (FACS Calibur, Becton Dickinson, Heidelberg, Germany, 488 nm excitation wavelength) in fluorescence channel FL-3 (linear scale, >670 nm emission wavelength). In parallel, cells with degraded DNA were defined by the subG1 population of the PI histogram recorded in fluorescence channel FL-2 (logarithmic scale).

For determination of cells were loaded in NaCl ringer solution (see above) for 0.5 h with fluo-3-AM (2 μM in NaCl ringer, Calbiochem; Bad Soden, Germany) and recorded in fluorescence channels FL-1 (logarithmic scale, 515–545 nm emission wavelengths). As loading control for fluo-3, cells were incubated with the Ca2+ ionophore ionomycin (1 μM for 10 min) prior to analysis by flow cytometry. Data were analyzed with the FCS Express 3 software (De Novo Software, Los Angeles, CA, USA).

2.8. Statistics

Data are expressed as means ± SE and statistical analysis was made by normal or Welch-corrected two-tailed -test or ANOVA where appropriate using InStat software (GraphPad Software Inc., San Diego, CA, USA).

3. Results and Discussion

3.1. Modulation of on Channel Activity by Ionizing Radiation

To assess the effect of ionizing radiation (IR) of ion channel activity, Jurkat cells were irradiated with 10 Gy and whole-cell currents were recorded at different time periods after IR. As shown in Figures 1(a) and 1(b), IR induced an increase in whole-cell currents 2–6 h after IR. Substitution of Na+ in the bathing solution by Ca2+ or the impermeable Na+ substitute NMDG+ indicated both cation-selectivity and Ca2+ permeability of the IR-induced currents (Figures 1(c)1(e)).

Figure 1: Ionizing radiation (IR) increases the cation and the Ca2+ conductance of the plasma membrane in human Jurkat T cell leukemia cells. (a, b) Current density-voltage relationships (I/V curves, a) and conductance densities (b) of Jurkat cells at different time periods (as indicated) after IR with 0 Gy (control, open circles and bar) or 10 Gy (closed symbols and bars). Currents were recorded in whole-cell voltage-clamp mode with K-gluconate/KCl pipette and NaCl bath solution and elicited by 9 voltage square pulses to voltages between −80 mV and +80 mV (20 mV increments). Conductance densities were calculated for the inward currents as shown by the blue and red line in (a) for control cells and irradiated cells (2–6 h after IR), respectively. (c, d) I/V curves of control (c) and irradiated Jurkat cells (2–6 h after 10 Gy, d) recorded as in (a) with NaCl bath solutions (circles) or after replacement of Na+ with Ca2+ (squares) or the impermeable cation N-methyl-D-glucamine (NMDG, triangles). (e) Ca2+ conductance density of control cells (open bar) and irradiated Jurkat cells (2–6 h after 10 Gy, closed bar). The blue and red line in (c) and (d), respectively, show the voltage range used for calculation of the Ca2+ conductance densities. Data are means ± SE, for the 46–49 h values in (a) and for all other data. and indicate and 0.01 as tested by ANOVA (b) and Welch-corrected -test (e), respectively.

Next, the functional expression of TRPM2 channels and its dependence on Bcl-2 was determined in Jurkat cells. Such dependence was suggested by a positive correlation of the TRPM2 and Bcl-2 mRNA abundances in 178 hematopoietic and lymphoid tissue cancer cell lines of the Novartis and Broad Institute Cancer Cell Line Encyclopedia (Figure 2(a)). In the Jurkat cell model, in contrast, TRPM2 protein abundance seemed to be lower in Bcl-2-overexpressing (Jurkat-Bcl-2) cells as in the control vector-transfected (Jurkat-vector) cells as suggested by immunoblotting (Figure 2(b)). IR did not modify total TRPM2 protein content of the cells (Figure 2(b)).

Figure 2: T cell leukemia cells functionally express TRPM2 Ca2+-permeable cation channels and TRPM2 expression correlates with that of the antiapoptotic protein Bcl-2. (a) Dot blot showing the relative mRNA abundances of TRPM2 and Bcl-2 in 178 hematopoietic and lymphoid tissue cancer cell lines. Data are from the Novartis and Broad Institute Cancer Cell Line Encyclopedia. (b) Immunoblots from whole lysates of irradiated (0, 5, or 10 Gy, 4 h after IR) stably transfected control (Jurkat-vector) and Bcl-2-overexpressing (Jurkat-Bcl-2) cells probed against Bcl-2, TRPM-2, and β-actin. (c) Current tracings recorded as in Figure 1(a) in Jurkat-Bcl-2 cells with vehicle alone (1st tracings) or in an unpaired experiment with the TRPM-2 activator ADP-ribose (1 μM) in the pipette (2nd–4th tracings). The recordings with ADP-ribose were performed before (2nd tracings, control), during (3rd tracings, ACA), and after (4th tracings, wash-out) bath application of the TRPM-2 inhibitor N-(p-amylcinnamoyl)-anthranilic acid (ACA, 20 μM, zero currents are shown by red lines). (d) I/V curves of the mean whole cell currents (± SE, ) of Jurkat-Bcl-2 cells recorded the absence (left) or presence of the TRPM2-activator ADP-ribose (right) in the pipette before (open circles) and after bath superfusion with the TRPM2 inhibitor ACA (closed triangles). (e) Single channel characteristics of the ADP-ribose-stimulated channel. Unitary current transitions were apparent in whole-cell currents tracings as depicted here for −100 mV and +100 mV clamp-voltage in the upper panel. The lower panel shows the relationship between unitary current transitions and voltage indicating a unitary conductance of about 50 pS.

To activate TRPM2 in Jurkat cells, whole-cell currents were recorded with the TRPM2 agonist ADP-ribose in the pipette and compared in unpaired experiments with those recorded under control conditions. Intracellular ADP-ribose stimulated a whole-cell current fraction which was sensitive to the unspecific TRPM2 inhibitor ACA [36] (Figures 2(c) and 2(d)). Importantly, ADP-ribose-stimulated currents exhibited unitary current transitions with a unitary conductance of some 50 pS as reported for heterologously expressed TRPM2 channels [37] (Figure 2(e)). Together, these data indicated functional expression of TRPM2 in Jurkat cells.

3.2. Mitochondrial Superoxide Anion Formation: Effect of Ionizing Radiation, Bcl-2 Overexpression, and TRPM2 Inhibition

To assess IR-stimulated formation of superoxide anion by mitochondria and to estimate a potential role of TRPM2 channels herein, Jurkat-Bcl-2 and Jurkat-vector cells were irradiated (0 or 10 Gy), postcultured for 6 h, and incubated for 10 min with the superoxide anion-sensitive fluorescence dye MitoSOX. The dye incubation was performed in the absence or presence of the TRPM2 inhibitor ACA. As shown in Figure 3(a), upper panel, and Figure 3(b), three distinct cell populations with low, intermediate, or high MitoSOX fluorescence were apparent. The latter two showed lower cell sizes as compared to the low-fluorescent population, suggestive of superoxide anion formation-associated cell shrinkage. Staining of the cells in parallel experiments with the inner mitochondrial membrane potential () specific dye TMRE indicated dissipation of in most of the shrunken cells (Figure 3(a), lower panel) suggesting that the vast majority of cells with intermediate and high MitoSOX fluorescence underwent apoptotic cell death.

Figure 3: IR increases mitochondrial superoxide anion formation in Bcl-2-overexpressing cells. (a, b) Dot plots showing forward scatter and the superoxide anion-selective MitoSOX fluorescence (a, upper panel, and b) as well as the inner mitochondrial membrane potential -specific TMRE fluorescence (a, lower panel) of Jurkat-vector- (1st and 2nd panels) and Jurkat-Bcl-2 cells (3rd and 4th panels) 6 h after irradiation with 0 Gy (1st and 3rd panels) or 10 Gy (2nd and 4th panels). Incubation (10 min at 37°C) with the superoxide anion-sensitive fluorescence dye was carried out in the absence (a) or presence (b) of the TRPM2 inhibitor ACA (20 μM). Three distinct cell populations with low (black), intermediate (lilac), or high (blue) superoxide anion formation were apparent. The majority of intermediate and high superoxide anion-forming cells exhibited a low forward scatter which was associated with dissipation of (a, lower panel). (c) Mean (± SE, ) MitoSOX fluorescence intensity in the low-fluorescent populations of 0 Gy- (open bars) or 10 Gy-irradiated (closed bars, 6 h after irradiation) Jurkat-vector- (left) and Jurkat-Bcl-2 cells (right). (d, e) Mean (± SE, ) fraction of MitoSOX low-fluorescent (d) and high-fluorescent Jurkat-vector- (1st, 2nd, 5th, and 6th bars) and Jurkat-Bcl-2 cells (3rd, 4th, 7th, and 8th bars) 6 h after irradiation with 0 Gy (open bars) or 10 Gy (closed bars). The incubation with the fluorescence dye was carried out in the absence (1st–4th bars) or presence (5th8th bars) of ACA (20 μM). and indicate and , respectively, ANOVA.

The low-fluorescent, nonshrunken cell population was larger and exhibited significant lower superoxide anion formation in Jurkat-Bcl-2 cells as compared to this population in Jurkat-vector cells (open bars in Figures 3(c) and 3(d), left). In the low-fluorescent populations, irradiation significantly increased the superoxide formation only in Jurkat-Bcl-2 cells to levels which still remained below those of control or irradiated Jurkat-vector cells (compare open and closed bars in Figure 3(c)). Importantly, ACA slightly but significantly (, ANOVA) decreased superoxide anion formation in unirradiated (from 20.9 ± 0.21 to 18.2 ± 0.22 relative units, ) and irradiated (from 23.8 ± 0.26 to 21.6 ± 0.79 rel. units, ) low-fluorescent Jurkat-Bcl-2 cells while having no inhibiting effect on superoxide anion formation in low-fluorescent Jurkat-vector cells (data not shown). IR effects on the intermediate- or high-fluorescent populations of both cell clones, in contrast, were not apparent (Figure 3(a)). ACA markedly decreased the superoxide formation of the intermediate- or high-fluorescent populations in all control or irradiated cells (compare Figures 3(a) and 3(b)) resulting in the disappearance of the high-fluorescent cells (Figure 3(e)).

Combined, these data demonstrate lower mitochondrial superoxide anion formation in Jurkat-Bcl-2 cells as compared to Jurkat-vector cells. Only in the former cells, IR induced an increase in superoxide anion formation. In addition, superoxide anion formation was lowered by the TRPM2 inhibitor ACA in cells of both clones independent of IR stress. This might suggest a contribution of TRPM2-mediated Ca2+ uptake to mitochondrial ROS formation.

3.3. Ionizing Radiation-Stimulated Ca2+ Uptake: Regulation by Bcl-2 and Involvement of TRPM2 Channels

To determine IR-induced changes in TRPM2 activity, irradiated (0 or 5 Gy) Jurkat-Bcl-2 and Jurkat-vector cells were whole-cell recorded in the absence and presence of ACA (Figures 4(a)4(c)). The ACA-sensitive current fraction of nonirradiated cells was higher in Jurkat-vector than in Jurkat-Bcl-2 cells (compare 1st with 3rd and 5th with 7th bar in Figure 4(c), resp.) which might reflect the observed differences in TRPM2 protein abundance and which is in accordance with the observed differences in mitochondrial ROS formation. IR (5 Gy) stimulated an increase in the ACA-sensitive currents predominately in Jurkat-Bcl-2 cells (Figure 4(c)) which again might be mirrored by the observed IR sensitivity of mitochondrial ROS formation exclusively in Jurkat-Bcl-2 cells.

Figure 4: IR stimulates Ca2+ entry through TRPM2 channels especially in Bcl-2-overexpressing Jurkat cells. (a) Whole-cell current tracings recorded in Jurkat-Bcl-2 cells irradiated with 0 Gy (1st and 2nd tracings) or 5 Gy (3rd and 4th tracings, 2 h after IR). Records were obtained in unpaired experiments as described in Figure 1(a) before (1st and 3rd tracings) and during bath application of the TRPM2 inhibitor ACA (20 μM, 2nd and 4th tracings). (b) Relationship of the mean (± SE, ) current density and the voltage recorded as in (a) in Jurkat-Bcl-2 cells irradiated with 0 Gy (open circles) or 5 Gy (closed triangles). (c) Mean (± SE, ) conductance density of control (0 Gy, open bars) and irradiated (5 Gy, 2–5 h after IR) Jurkat-vector (left) and Jurkat-Bcl-2 cells (right) recorded as in (a) in the absence or presence of ACA. Conductance densities were calculated for the outward currents as shown by the blue and red line in (b) for control and irradiated cells, respectively. (d, e) Mean (± SE, ) fura-2 340/380 nm ratio (d) and delta fura-2 ratio (e) as measures of cytosolic free Ca2+ concentration and Ca2+ entry in Ca2+-depleted cells, respectively. Ca2+-specific fura-2 fluorescence was recorded by imaging in control (0 Gy, open circles and bars) and irradiated (5 Gy, closed triangles and bars, 1.5–5 h after IR) Jurkat-vector and Jurkat-Bcl-2 cells using extracellular Ca2+ removal/readdition protocol. Ca2+ readdition was performed in the absence (vehicle) or presence of ACA (20 μM). indicates , ANOVA.

In accordance with an IR-induced increase in TRPM2 activity, IR stimulated an ACA-sensitive Ca2+ uptake as measured by fura-2 Ca2+ imaging using an extracellular Ca2+ depletion/repletion protocol (Figure 4(d)). In contrast to the ACA-sensitive basal whole cell currents (Figure 4(b)), basal (ACA-sensitive) Ca2+ uptake was higher in Jurkat-Bcl-2 than in Jurkat-vector cells (compare 1st with 5th bar in Figure 4(e)). Similarly to the whole-cell currents, IR (5 Gy) stimulated a larger Ca2+ uptake in Jurkat-Bcl-2 as compared to Jurkat-vector cells (compare 2nd with 6th bar in Figure 4(e)). In the presence of ACA, Ca2+ uptake did not differ between control and irradiated Jurkat-vector and Jurkat-Bcl-2 cells (3rd, 4th, 7th, and 8th bar in Figure 4(e)). Together, these observations indicated an IR-stimulated Bcl-2-regulated Ca2+ uptake in Jurkat cells which probably involves TRPM2 channels.

3.4. Role of TRPM2 Channels in Ionizing Radiation-Stimulated Activation of Ca2+ Effector Proteins Involved in Cell Cycle Arrest

This IR-stimulated Ca2+ uptake might be hazardous for the cells leading to Ca2+ overflow and subsequent cell death. In fact, 24 h after IR with 10 Gy, some 25% of the Jurkat cells exhibited a highly increased as deduced from fluo-3 flow cytometry (Figures 5(a) and 5(b)). Ca2+ uptake might also contribute to Ca2+ signaling that is required for DNA damage response of the irradiated T cell leukemia cells. IR (5 Gy) stimulated autophosphorylation and activation of Ca2+/calmodulin-dependent protein kinase II (CaMKII) isoforms and phosphorylation-dependent inactivation of the CaMKII downstream target cdc25b as suggested by immunoblotting (Figure 5(c)). Inactivation of the phosphatase cdc25b was parallel by radiation-induced phosphorylation-dependent inactivation of the cdc25b substrate cdc2 (Figure 5(c)). This might hint to an involvement of Ca2+ effector proteins such as CaMKII in G2/M arrest as observed in PI flow cytometry 24 h after IR (5 Gy, Figure 5(d)).

Figure 5: IR induces Ca2+ signaling and a G2/M cell cycle arrest in Jurkat cells. (a) Dot plot recorded by flow cytometry showing the Ca2+-specific fluo-3 fluorescence intensity in dependence on side scatter of Jurkat cells 24 h after IR with 0 Gy (grey) or 10 Gy (red). (b) Mean (± SE, ) percentage of control and irradiated Jurkat cells with high cytosolic free Ca2+ concentrations (determined by fluo-3 fluorescence in flow cytometry as described in (a), indicates , Welch-corrected -test). (c) Immunoblots from whole lysates of irradiated (0 or 5 Gy, 4 h after IR) Jurkat cells probed against phosphorylated and total Ca2+/CaM-dependent kinase II (CaMKII) isoforms, against the phosphorylated and total phosphatase cdc25b, the phosphorylated cell division cycle protein 2 (cdc2), and β-actin for loading control. (d) Flow cytometry histogram depicting the fluorescence intensity of the DNA-specific dye propidium iodide (PI) in Jurkat cells 24 h after IR with 0 (black) or 5 Gy (red).

To confirm an involvement of TRPM2 and CaMKII in the stress response of Jurkat cells, Jurkat-Bcl-2 and Jurkat-vector cells were irradiated (0 or 5 Gy) and postincubated in the presence or absence of the TRPM2 inhibitors ACA or clotrimazole [38, 39] and kinase activities of the CaMKII isoforms and cdc2 and cell cycle distribution and cell death were analyzed by immunoblotting and PI flow cytometry, 4 h and 24 after IR, respectively. ACA decreased the basal and radiation-induced abundance of phosphorylated CaMKII in Jurkat-Bcl-2 and Jurkat-vector cells (Figure 6(a), 1st and 2nd blot). Most importantly, ACA blocked the radiation-induced phosphorylation-dependent inactivation of cdc2 in both genotypes (Figure 6(a), 3rd blot) suggesting a functional significance of ACA-sensitive Ca2+ entry for G2/M cell cycle arrest. Accordingly, ACA and clotrimazole decreased the number of irradiated cells arrested in G2/M (Figures 6(b)6(e)) and increased the number of dead cells. ACA- and clotrimazole-induced cell death was more pronounced in irradiated Jurkat-vector than in Jurkat-Bcl-2 cells (subG1 population, Figures 6(b)6(e)).

Figure 6: Ca2+-signaling via ACA-sensitive Ca2+ entry contributes to IR-induced G2/M cell cycle arrest and decreases IR-induced cell death of Jurkat cells. (a) Immunoblots from whole lysates of irradiated (0 or 5 Gy, 4 h after IR) Jurkat-vector and Jurkat-Bcl-2 cells probed against phospho-CaMKII and total CaMKII isoforms, against phospho-cdc2, and against β-actin. Cells were irradiated and postincubated in the presence of ACA (0 or 20 μM). (b, d) Histograms showing the DNA-specific PI fluorescence intensity of irradiated (5 Gy, 24 h after IR) Jurkat-vector cells pre- (0.25 h) and postincubated (24 h) with 0 μM (black) or 20 μM ACA (red) in (b) or 0 μM (black) or 20 μM clotrimazole (CLT, red) in (d). (c, e) Mean (± SE, ) percentage of irradiated (0 Gy, open bars, or 5 Gy, closed bars) and ACA- in (d) or CLZ- in (e) (both 0 or 20 μM) cotreated Jurkat-vector and Jurkat-Bcl-2 cells arrested in G2 phase of cell cycle (upper line) or belonging to the dead cells accumulating in the subG1 population (lower line). (f) Knock-down of TRPM2 by RNA interference mimics the effect of ACA. Electroporation with TRPM2-specific siRNA decreases the TRPM2 protein abundance in Jurkat-vector cells to about a half of that of nontargeting RNA- (nt RNA-) transfected control cells as analyzed by TRPM2 and β-actin immunoblots, 48 h after electroporation (insert, mock: electroporation without RNA). Lower line: mean (± SE, ) percentage of irradiated (0 Gy, open bars, or 5 Gy, closed bars, 24 h after IR) in G2/M arrest (left) or in subG1 population as analyzed by PI staining and flow cytometry as shown in (b, d). Cells were either mock-electroporated or transfected with nt RNA or TRPM2-specific siRNA. Mock and nt RNA data did not differ and were pooled. and indicate and , ANOVA, respectively.

Finally, the function of TRPM2 in radiation-induced G2/M arrest of Jurkat cells was directly tested by TRPM2 knock-down. Transfection of Jurkat-vector cells with TRPM2 siRNA resulted in downregulation of TRPM2 protein level as compared to nontargeting (nt) RNA-transfected cells (Figure 6(f), insert). Transfected Jurkat cells were irradiated (0 or 5 Gy) and G2/M arrest and cell death analyzed 24 h thereafter. TRPM2 knock-down exerted small but significant effects on radiation-induced G2/M arrest and cell death mimicking those of ACA and clotrimazole (Figure 6(f)).

3.5. Regulation of TRPM2-Mediated Ca2+ Influx by Mitochondria and Bcl-2

ADP-ribose is liberated in the mitochondria from, for example, NAD-dependent deacetylation intermediates, from mono- or polyADP-ribosylated proteins, or from NAD+, and released into the cytosol [19]. Oxidative and nitrosative stress have been demonstrated to stimulate the mitochondrial release of ADP-ribose into the cytosol which in turn activates TRPM2 channels in the plasma membrane resulting in Ca2+ entry and depolarization of the membrane potential [16]. Since an elevated may disinhibit the respiration change leading to hyperpolarisation and superoxide anion formation and, eventually, to mitochondrial Ca2+ overload and dissipation, TRPM2 activation has been proposed to amplify signals that trigger cell death (for review see [27]).

The present study demonstrates that irradiated human T cell leukemia cells may utilize the TRPM2 “death channel” for prosurvival Ca2+ signaling. Noteworthy, IR-induced TRPM2 currents and Ca2+ entry were larger in cells overexpressing Bcl-2 pointing to a crosstalk between Bcl-2 in the ER and outer mitochondrial membrane and TRPM2 in the plasma membrane. The correlation between TRPM2 and Bcl-2 mRNA abundances in a panel of lymphohematopoietic cancer cell lines (see Figure 2(a)) further suggests a functional interdependence between both proteins.

In some cell models, Bcl-2-overexpressing cells have been proposed to counteract the Bcl-2-mediated Ca2+ leakage from the stores by downregulating Ca2+ uptake through the plasma membrane (for review see [19]). In line with such compensatory mechanism might be the observation of the present study that Bcl-2-overexpressing Jurkat cells exhibited under basal conditions lower TRPM2 protein abundance, smaller ACA-sensitive currents in patch-clamp whole-cell recordings than the control vector-transfected cells (see Figure 2(b)).

In intact cells (i.e., in fura-2 Ca2+ imaging experiments, see Figure 4(e)), however, a basal ACA-sensitive Ca2+ uptake fraction was only apparent in Bcl-2-overexpressing cells suggestive of a TRPM2 inactivity in control cells under resting conditions. Compared to control cells, the more sustained Ca2+ uptake in Bcl-2-overexpressing cells (see Figures 4(d) and 4(e)) suggests that Bcl-2 overexpression might be associated with a set-point shift of the resting towards higher levels. Fura-2 Ca2+ imaging and fluo-3 flow cytometry recordings of the present study indeed demonstrated a higher basal in constitutively and inducibly Bcl-2-overexpressing Jurkat cells as compared to the respective control cells (see Supplementary Figure A, in Supplementary Material available online at http://dx.doi.org/10.1155/2016/8026702). Elevated levels reportedly facilitate TRPM2 activation by ADP-ribose [40]. The observed basal ACA-sensitive Ca2+ uptake that occurred exclusively in Bcl-2-overexpressing cells might, therefore, be simply explained by a higher basal in Bcl-2-overexpressing as compared to control cells.

Noteworthy, despite higher basal , Bcl-2-overexpressing cells exhibited lower basal mitochondrial ROS formation than control cells (see Figure 3(c)) suggestive of a Bcl-2-mediated protection of mitochondrial superoxide anion formation. As a matter of fact, a direct promoting function of mitochondrial superoxide anion formation has been attributed to the Bcl-2 opponent Bax in neuronal cells [41].

3.6. Rearrangements of the Ca2+ Signalosome in Tumor Cells: Functional Significance for Cell Cycle Control and Stress Response

In many tumor entities rearrangements of the Ca2+ signalosome have been reported. In prostate cancer, for instance, malignant progression is reportedly accompanied by TRPM8-mediated Ca2+ store depletion and downregulation of store-dependent Ca2+ entry across the plasma membrane. In exchange, TRP channels such as TRPV6 are upregulated in the plasma membrane of advanced prostate cancer cells which have been proposed to generate in concert with IK K+ channels survival and growth factor-independent Ca2+ signaling (for review see [42]).

In the present study, IR stimulated the ACA-sensitive currents of Jurkat cells in patch-clamp recordings and the ACA-sensitive Ca2+ uptake in fura-2 imaging experiments suggesting an IR-induced increase in TRPM2 activity. IR-induced modifications of ion channel activity have been reported in different tumor entities where they contribute to stress evasion [43], glucose fueling [44, 45], cell cycle control [46, 47], or radioresistance [48].

The p53-mutated Jurkat cells [49] accumulate in G2M cell cycle arrest upon IR-mediated DNA damage (see Figure 5(d)). The proposed IR-stimulated Ca2+ entry through TRPM2 channels most probably contributed to the G2M cell cycle arrest. This was evident from the observation of the present study that two nonspecific TRPM2 inhibitors or TRPM2 knock-down decreased the number of cells accumulating in G2 and increased the number of dead cells (see Figure 6). One might speculate that TRPM2 inhibition or knock-down overrides G2M cell cycle arrest and forces cells with unrepaired DNA damage into mitosis.

This scenario is strengthened by the observation that IR promoted the -dependent phosphorylation of CaMKIIs and their downstream targets cdc25b and cdc2 in an ACA-sensitive manner (see Figures 5(c) and 6(a)). CaMKIIs phosphorylate and thereby inactivate the phosphatase cdc25b which results in accumulation of the phosphorylated, inactive form of the mitosis promoting factor subunit cdc2 [47]. Combined, these observations suggest that IR-dependent TRPM2 activation contributes to Ca2+ signals that are able to induce autophosphorylation and thereby activation of CaMKIIs.

Likewise, irradiated human myeloid leukemia cells have been shown to generate Ca2+ signals by the concerted action of TRPV5/6 and Kv3.4 K+ channels in the plasma membrane. These Ca2+ signals program G2M cell cycle arrest similarly to proposed mechanism of the present study via CaMKIIs, cdc25b, and cdc2 [46, 47]. K+ channel activity in close vicinity to Ca2+ entry pathways maintains a high inwardly directed driving force for Ca2+ and, thus, is indispensable for robust Ca2+ signals. In analogy to the leukemia cells [47], IR induced the coactivation of IK K+ channels in the plasma membrane of Jurkat cells (see supplementary Figure B). This points to both a common signaling in irradiated myeloid and lymphoblastic leukemia cells and the possibility that functionally equivalent Ca2+ signals can be generated during DNA damage response by different sets of TRP and K+ channels in the plasma membrane.

3.7. Conclusions

Plasma membrane TRPM2 channels have been attributed tumor suppressor function in several tumor entities. The Ca2+ signalosome of human T cell leukemia cells comprises TRPM2 channels that are activated during DNA damage response. In particular, irradiated Jurkat cells utilize TRPM2 to control the G2/M cell cycle arrest probably via activation of the Ca2+ effector protein CaMKII and subsequent inhibition of cdc25b and cdc2. The antiapoptotic protein Bcl-2 in the ER or outer mitochondrial membrane even fosters TRPM2 activity presumably by inducing higher levels and decreases at the same time mitochondrial ROS formation. By doing so, Bcl-2-overexpressing cells may harness TRPM2-generated Ca2+ signals without running into the risk of hazardous mitochondrial ROS formation. Thus, Bcl-2 function on mitochondrial integrity and stress-induced TRPM2-mediated Ca2+ signaling cooperate in resistance to radiation therapy in T cell leukemia cells.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Dominik Klumpp cultured the cells and carried out patch-clamp, Ca2+ imaging, flow cytometry, TRPM2 knock-down, and immunoblotting. Milan Misovic performed patch-clamp recording and Ca2+ imaging. Kalina Szteyn did patch-clamp experiments. Ekaterina Shumilina analyzed the patch-clamp and imaging data, did the statistics, and compiled the figure parts with these methods. Justine Rudner designed and supervised the study, analyzed the flow cytometry and immunoblotting data, did the statistics, and wrote part of the paper draft. Stephan M. Huber co-conceived and co-supervised the study, compiled the remaining figure parts, and wrote the remaining paper draft. All authors read and approved the final paper. Justine Rudner and Stephan M. Huber contributed equally to this work and, thus, share senior authorship.

Acknowledgments

This work was supported by grants from the German Research Foundation DFG (RU 1641/1-1) donated to Justine Rudner and from the Wilhelm Sander Stiftung (2011.083.1) donated to Stephan M. Huber. Dominik Klumpp was supported by the DFG International Graduate School 1302 (TP T9 SH). The authors thank Heidrun Faltin and Ilka Müller for excellent technical assistance.

References

  1. D. E. Clapham, “TRP channels as cellular sensors,” Nature, vol. 426, no. 6966, pp. 517–524, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Nilius, G. Owsianik, T. Voets, and J. A. Peters, “Transient receptor potential cation channels in disease,” Physiological Reviews, vol. 87, no. 1, pp. 165–217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Naziroğlu, “New molecular mechanisms on the activation of TRPM2 channels by oxidative stress and ADP-ribose,” Neurochemical Research, vol. 32, no. 11, pp. 1990–2001, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Nagamine, J. Kudoh, S. Minoshima et al., “Molecular cloning of a novel putative Ca2+ channel protein (TRPC7) highly expressed in brain,” Genomics, vol. 54, no. 1, pp. 124–131, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Nazıroğlu and A. Lückhoff, “A calcium influx pathway regulated separately by oxidative stress and ADP-ribose in TRPM2 channels: single channel events,” Neurochemical Research, vol. 33, no. 7, pp. 1256–1262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Inamura, Y. Sano, S. Mochizuki et al., “Response to ADP-ribose by activation of TRPM2 in the CRI-G1 insulinoma cell line,” Journal of Membrane Biology, vol. 191, no. 3, pp. 201–207, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Heiner, J. Eisfeld, and A. Lückhoff, “Role and regulation of TRP channels in neutrophil granulocytes,” Cell Calcium, vol. 33, no. 5-6, pp. 533–540, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A.-L. Perraud, A. Fleig, C. A. Dunn et al., “ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology,” Nature, vol. 411, no. 6837, pp. 595–599, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Hara, M. Wakamori, M. Ishii et al., “LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death,” Molecular Cell, vol. 9, no. 1, pp. 163–173, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Ishii, A. Oyama, T. Hagiwara et al., “Facilitation of H2O2-induced A172 human glioblastoma cell death by insertion of oxidative stress-sensitive TRPM2 channels,” Anticancer Research, vol. 27, no. 6, pp. 3987–3992, 2007. View at Google Scholar · View at Scopus
  11. X. Zeng, S. C. Sikka, L. Huang et al., “Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation,” Prostate Cancer and Prostatic Diseases, vol. 13, no. 2, pp. 195–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Zhang, I. Hirschler-Laszkiewicz, Q. Tong et al., “TRPM2 is an ion channel that modulates hematopoietic cell death through activation of caspases and PARP cleavage,” American Journal of Physiology—Cell Physiology, vol. 290, no. 4, pp. C1146–C1159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Zhang, X. Chu, Q. Tong et al., “A novel TRPM2 isoform inhibits calcium influx and susceptibility to cell death,” Journal of Biological Chemistry, vol. 278, no. 18, pp. 16222–16229, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Orfanelli, A.-K. Wenke, C. Doglioni, V. Russo, A. K. Bosserhoff, and G. Lavorgna, “Identification of novel sense and antisense transcription at the TRPM2 locus in cancer,” Cell Research, vol. 18, no. 11, pp. 1128–1140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Adachi, H. Tanaka, S. Nonomura, H. Hara, S.-I. Kondo, and M. Hori, “Plasma-activated medium induces A549 cell injury via a spiral apoptotic cascade involving the mitochondrial-nuclear network,” Free Radical Biology and Medicine, vol. 79, pp. 28–44, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A.-L. Perraud, C. L. Takanishi, B. Shen et al., “Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels,” The Journal of Biological Chemistry, vol. 280, no. 7, pp. 6138–6148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Fonfria, I. C. B. Marshall, C. D. Benham et al., “TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase,” British Journal of Pharmacology, vol. 143, no. 1, pp. 186–192, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Eisfeld and A. Lückhoff, “TRPM2,” in Transient Receptor Potential (TRP) Channels, vol. 179 of Handbook of Experimental Pharmacology, pp. 237–252, Springer, Berlin, Germany, 2007. View at Publisher · View at Google Scholar
  19. C. Dölle, J. G. M. Rack, and M. Ziegler, “NAD and ADP-ribose metabolism in mitochondria,” The FEBS Journal, vol. 280, no. 15, pp. 3530–3541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Giacomello, I. Drago, P. Pizzo, and T. Pozzan, “Mitochondrial Ca2+ as a key regulator of cell life and death,” Cell Death and Differentiation, vol. 14, no. 7, pp. 1267–1274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Pizzo, I. Drago, R. Filadi, and T. Pozzan, “Mitochondrial Ca2+ homeostasis: mechanism, role, and tissue specificities,” Pflügers Archiv—European Journal of Physiology, vol. 464, no. 1, pp. 3–17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Braun, D. Klumpp, J. Hennenlotter et al., “UCP-3 uncoupling protein confers hypoxia resistance to renal epithelial cells and is upregulated in renal cell carcinoma,” Scientific Reports, vol. 5, article 13450, 2015. View at Publisher · View at Google Scholar
  23. J. Rudner, V. Jendrossek, and C. Belka, “New insights in the role of Bcl-2 Bcl-2 and the endoplasmic reticulum,” Apoptosis, vol. 7, no. 5, pp. 441–447, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. A. Oakes, J. T. Opferman, T. Pozzan, S. J. Korsmeyer, and L. Scorrano, “Regulation of endoplasmic reticulum Ca2+ dynamics by proapoptotic BCL-2 family members,” Biochemical Pharmacology, vol. 66, no. 8, pp. 1335–1340, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Pinton and R. Rizzuto, “Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum,” Cell Death and Differentiation, vol. 13, no. 8, pp. 1409–1418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Monaco, T. Vervliet, H. Akl, and G. Bultynck, “The selective BH4-domain biology of Bcl-2-family members: IP3Rs and beyond,” Cellular and Molecular Life Sciences, vol. 70, no. 7, pp. 1171–1183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. S. M. Huber, L. Butz, B. Stegen et al., “Ionizing radiation, ion transports, and radioresistance of cancer cells,” Frontiers in Physiology, vol. 4, article 212, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Rudner, A. Lepple-Wienhues, W. Budach et al., “Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis,” Journal of Cell Science, vol. 114, no. 23, pp. 4161–4172, 2001. View at Google Scholar · View at Scopus
  29. J. Rudner, S. J. Elsaesser, A.-C. Müller, C. Belka, and V. Jendrossek, “Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis,” Biochemical Pharmacology, vol. 79, no. 1, pp. 10–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Rudner, V. Jendrossek, K. Lauber, P. T. Daniel, S. Wesselborg, and C. Belka, “Type I and type II reactions in TRAIL-induced apoptosis—results from dose-response studies,” Oncogene, vol. 24, no. 1, pp. 130–140, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Rudner, S. J. Elsaesser, V. Jendrossek, and S. M. Huber, “Anti-apoptotic Bcl-2 fails to form efficient complexes with pro-apoptotic Bak to protect from Celecoxib-induced apoptosis,” Biochemical Pharmacology, vol. 81, no. 1, pp. 32–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. P. H. Barry and J. W. Lynch, “Liquid junction potentials and small cell effects in patch-clamp analysis,” The Journal of Membrane Biology, vol. 121, no. 2, pp. 101–117, 1991. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Cerami, J. Gao, U. Dogrusoz et al., “The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data,” Cancer Discovery, vol. 2, no. 5, pp. 401–404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Gao, B. A. Aksoy, U. Dogrusoz et al., “Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal,” Science Signaling, vol. 6, no. 269, p. pl1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Barretina, G. Caponigro, N. Stransky et al., “The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity,” Nature, vol. 483, no. 7391, pp. 603–607, 2012. View at Publisher · View at Google Scholar
  36. R. Kraft, C. Grimm, H. Frenzel, and C. Harteneck, “Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acid,” British Journal of Pharmacology, vol. 148, no. 3, pp. 264–273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. K. R. Laub, K. Witschas, A. Blicher, S. B. Madsen, A. Lückhoff, and T. Heimburg, “Comparing ion conductance recordings of synthetic lipid bilayers with cell membranes containing TRP channels,” Biochimica et Biophysica Acta—Biomembranes, vol. 1818, no. 5, pp. 1123–1134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Hill, S. McNulty, and A. D. Randall, “Inhibition of TRPM2 channels by the antifungal agents clotrimazole and econazole,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 370, no. 4, pp. 227–237, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. K. K. H. Chung, P. S. Freestone, and J. Lipski, “Expression and functional properties of TRPM2 channels in dopaminergic neurons of the substantia nigra of the rat,” Journal of Neurophysiology, vol. 106, no. 6, pp. 2865–2875, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. F. J. P. Kühn, I. Heiner, and A. Lückhoff, “TRPM2: a calcium influx pathway regulated by oxidative stress and the novel second messenger ADP-ribose,” Pflugers Archiv European Journal of Physiology, vol. 451, no. 1, pp. 212–219, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. R. A. Kirkland, G. M. Saavedra, B. S. Cummings, and J. L. Franklin, “Bax regulates production of superoxide in both apoptotic and nonapoptotic neurons: role of caspases,” Journal of Neuroscience, vol. 30, no. 48, pp. 16114–16127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. S. M. Huber, “Oncochannels,” Cell Calcium, vol. 53, no. 4, pp. 241–255, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Steinle, D. Palme, M. Misovic et al., “Ionizing radiation induces migration of glioblastoma cells by activating BK K+ channels,” Radiotherapy and Oncology, vol. 101, no. 1, pp. 122–126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Dittmann, C. Mayer, H. P. Rodemann, and S. M. Huber, “EGFR cooperates with glucose transporter SGLT1 to enable chromatin remodeling in response to ionizing radiation,” Radiotherapy and Oncology, vol. 107, no. 2, pp. 247–251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. S. M. Huber, M. Misovic, C. Mayer, H.-P. Rodemann, and K. Dittmann, “EGFR-mediated stimulation of sodium/glucose cotransport promotes survival of irradiated human A549 lung adenocarcinoma cells,” Radiotherapy and Oncology, vol. 103, no. 3, pp. 373–379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Heise, D. Palme, M. Misovic et al., “Non-selective cation channel-mediated Ca2+-entry and activation of Ca2+/calmodulin-dependent kinase II contribute to G2/M cell cycle arrest and survival of irradiated leukemia cells,” Cellular Physiology and Biochemistry, vol. 26, no. 4-5, pp. 597–608, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Palme, M. Misovic, E. Schmid et al., “Kv3.4 potassium channel-mediated electrosignaling controls cell cycle and survival of irradiated leukemia cells,” Pflugers Archiv European Journal of Physiology, vol. 465, no. 8, pp. 1209–1221, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Stegen, L. Butz, L. Klumpp et al., “Ca2+-activated IK K+ channel blockade radiosensitizes glioblastoma cells,” Molecular Cancer Research, vol. 13, no. 9, pp. 1283–1295, 2015. View at Publisher · View at Google Scholar
  49. J. Cheng and M. Haas, “Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines,” Molecular and Cellular Biology, vol. 10, no. 10, pp. 5502–5509, 1990. View at Publisher · View at Google Scholar · View at Scopus